BioCryst Pharmaceuticals
BCRX
#4651
Rank
S$2.92 B
Marketcap
S$11.52
Share price
0.34%
Change (1 day)
-10.09%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of March 2026 : S$0.59 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are S$0.59 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$0.66 B-0.97%
2024-12-31S$0.66 B-2.36%
2023-12-31S$0.68 B-7.4%
2022-12-31S$0.73 B-7.27%
2021-12-31S$0.79 B79.56%
2020-12-31S$0.44 B87.38%
2019-12-31S$0.23 B17.8%
2018-12-31S$0.20 B-15.86%
2017-12-31S$0.23 B83.35%
2016-12-31S$0.13 B-24.87%
2015-12-31S$0.17 B-4.3%
2014-12-31S$0.18 B192.12%
2013-12-31S$61.91 M-11.86%
2012-12-31S$70.24 M-34.02%
2011-12-31S$0.10 B-24.48%
2010-12-31S$0.14 B-29.38%
2009-12-31S$0.19 B64.82%
2008-12-31S$0.12 B-41.02%
2007-12-31S$0.20 B95.56%
2006-12-31S$0.10 B-36.45%
2005-12-31S$0.16 B211.97%
2004-12-31S$52.96 M3.59%
2003-12-31S$51.13 M-28.65%
2002-12-31S$71.66 M-34.5%
2001-12-31S$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
S$72.44 B 12,001.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$107.18 B 17,803.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$4.09 B 583.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$3.77 B 530.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.34 B 124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.65 B 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$10.75 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$36.24 M-93.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.88 B 214.16%๐Ÿ‡บ๐Ÿ‡ธ USA